Edwards Lifesciences Corporation (EW)
EW moved a median of -0.01% 30 minutes after news, and +0.07% by the close. How EW actually reacts to news — the realized, point-in-time move the market made, measured across 1,398 labeled events over the last three years with zero look-ahead.
EW’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | +0.02% | 52% | 1,397 |
| 30-min | -0.01% | 49% | 1,397 |
| 60-min | +0.01% | 51% | 1,397 |
| to close | +0.07% | 53% | 1,393 |
| Middle 50% of EW reactions | -0.38% to +0.56% |
|---|---|
| Median reaction (30-min) | -0.01% |
| Measured reactions | 1,398 |
Half of all Edwards Lifesciences Corporation news events land between -0.38% and +0.56% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How EW reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades | 73 | +0.10% | 51% | -0.41% |
| Analyst downgrades | 46 | +0.71% | 65% | +0.81% |
| Coverage initiations | 10 | +0.09% | 60% | +0.24% |
| Rating reiterations | 180 | -0.03% | 47% | -0.17% |
| Price-target raises | 71 | -0.13% | 37% | -0.21% |
| Price-target cuts | 34 | +0.11% | 62% | -0.42% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. See how EW ranks against every other measured name →
That’s how EW usually reacts — get an email when it moves on news →Email me when EW moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to EW's baseline. Nothing else.
Recent EW events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Edwards Lifesciences to Host Earnings Conference Call on November 4, 2026 | Press release | Business Wire | +0.61% | -1.00% | |
| Edwards Lifesciences to Host Investor Event in Conjunction With TCT | Press release | Business Wire | +0.04% | +1.77% | |
| Edwards Lifesciences Receives FDA Approval for AUTUS Valve, the First Surgical Pulmonary Valve for Pediatric Patients | Press release | Business Wire | -0.62% | -0.43% | |
| Edwards Lifesciences Comments on TAVR National Coverage Decision | Press release | Business Wire | -0.15% | -3.59% | |
| Did Edwards Lifesciences Corporation Insiders Breach their Fiduciary Duties to Shareholders? | Press release | PR Newswire | -1.28% | -2.64% | |
| Edwards Lifesciences to Present at the Deutsche Bank Healthcare Summit | Press release | Business Wire | -0.09% | -1.43% | |
| Form 8-K Edwards Lifesciences For: Aug 25 | SEC filing · Form 8-K | SEC EDGAR | +0.83% | +1.25% | |
| Form 10-Q Edwards Lifesciences For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +1.24% | -0.63% | |
| Form S-8 Edwards Lifesciences | SEC filing · Form S-8 | SEC EDGAR | +1.24% | -0.63% | |
| Edwards Lifesciences Reports Second Quarter Results | Press release | Business Wire | -0.74% | -6.10% | |
| Form 8-K Edwards Lifesciences For: Jul 23 | SEC filing · Form 8-K | SEC EDGAR | -0.74% | -6.10% | |
| Edwards Lifesciences to Host Earnings Conference Call on July 23, 2026 | Press release | Business Wire | +0.76% | -0.06% | |
| Did Edwards Lifesciences Corporation Insiders Breach their Fiduciary Duties to Shareholders? | Press release | PR Newswire | -0.40% | +0.87% | |
| Edwards’ Structural Heart Leadership Demonstrated Through Expanding Body of Scientific Evidence at New York Valves | Press release | Business Wire | -0.10% | +0.17% | |
| Form 11-K Edwards Lifesciences For: Dec 31 | SEC filing · Form 11-K | SEC EDGAR | -0.47% | +1.15% | |
| Form SD Edwards Lifesciences | SEC filing · Form SD | SEC EDGAR | -0.02% | -0.30% | |
| Form 8-K Edwards Lifesciences For: May 07 | SEC filing · Form 8-K | SEC EDGAR | -0.16% | -3.21% | |
| Form 10-Q Edwards Lifesciences For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.61% | -0.67% | |
| Edwards Lifesciences Announces Appointment of CFO | Press release | Business Wire | +0.42% | +0.46% | |
| Form 8-K Edwards Lifesciences For: May 02 | SEC filing · Form 8-K | SEC EDGAR | +0.42% | +0.46% | |
| Ten-Year Pivotal Data Demonstrate Long-Term Durability of Edwards Lifesciences’ Resilia Tissue | Press release | Business Wire | +0.28% | -0.39% | |
| Edwards Lifesciences to Present at the BofA Securities 2026 Health Care Conference | Press release | Business Wire | +0.83% | -2.20% | |
| Edwards Lifesciences Reports First Quarter Results | Press release | Business Wire | +1.96% | +2.00% | |
| Form 8-K Edwards Lifesciences For: Apr 23 | SEC filing · Form 8-K | SEC EDGAR | +1.96% | +2.00% | |
| Edwards Lifesciences to Host Earnings Conference Call on April 23, 2026 | Press release | Business Wire | +0.93% | +1.76% | |
| Marie O'Malley to Speak on Manufacturing Tradeoffs Panel at MPP West 2026 | Press release | PR Web | -0.37% | +0.23% | |
| Two Year Data on Edwards Lifesciences’ EVOQUE System Continue to Demonstrate Significant and Sustained Patient Benefits | Press release | Business Wire | +0.41% | +1.07% | |
| Form ARS Edwards Lifesciences For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | -0.57% | -3.01% | |
| Form DEF 14A Edwards Lifesciences For: May 07 | SEC filing · Form DEF | SEC EDGAR | -0.57% | -3.01% | |
| Form DEFA14A Edwards Lifesciences | SEC filing · Form DEFA14A | SEC EDGAR | -0.57% | -3.01% | |
| Edwards Lifesciences Advances Structural Heart Care Through Innovation and Purpose | Press release | Business Wire | +0.89% | +2.44% | |
| Form 10-K Edwards Lifesciences For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +0.89% | +2.44% | |
| Edwards Lifesciences to Present at the Barclays and Leerink Partners Global Healthcare Conferences | Press release | Business Wire | +0.15% | +0.54% | |
| Edwards Lifesciences to Present at Citi’s 2026 Unplugged Medtech and Life Sciences Access Day | Press release | Business Wire | -0.23% | -0.98% | |
| Halper Sadeh LLC Encourages Edwards Lifesciences Corporation Shareholders to Contact the Firm to Discuss Their Rights | Press release | GlobeNewswire | +0.28% | +0.48% | |
| Edwards Lifesciences Reports Fourth Quarter Results | Press release | Business Wire | -2.05% | +1.93% | |
| Form 8-K Edwards Lifesciences For: Feb 10 | SEC filing · Form 8-K | SEC EDGAR | -2.05% | +1.93% | |
| Edwards Lifesciences to Host Earnings Conference Call on February 10, 2026 | Press release | Business Wire | +1.12% | -0.34% | |
| Edwards Lifesciences to Present at the TD Cowen 46th Annual Health Care Conference | Press release | Business Wire | +1.20% | +1.49% | |
| Form 8-K Edwards Lifesciences For: Jan 09 | SEC filing · Form 8-K | SEC EDGAR | +0.04% | -0.85% | |
| Edwards Comments on JenaValve Acquisition | Press release | Business Wire | -0.93% | -3.36% | |
| HALPER SADEH LLC ENCOURAGES EDWARDS LIFESCIENCES CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS | Press release | PR Newswire | +0.04% | -0.09% | |
| FDA Approves Edwards Lifesciences' SAPIEN M3 Mitral Valve Replacement System as First Transseptal Transcatheter Therapy | Press release | Business Wire | +0.15% | +0.15% | |
| Edwards Lifesciences to Present at the 44th Annual J.P. Morgan Healthcare Conference | Press release | Business Wire | -0.32% | -1.20% | |
| Edwards Lifesciences Reaffirms Strategy for Sustainable, Differentiated Growth at Annual Investor Conference | Press release | Business Wire | +0.48% | +1.97% | |
| HALPER SADEH LLC ENCOURAGES EDWARDS LIFESCIENCES CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS | Press release | PR Newswire | +0.10% | -1.54% | |
| Edwards Champions American Heart Association Initiative to Reduce Deaths, Improve Care for Patients With Heart Valve Disease | Press release | Business Wire | +0.64% | +1.85% | |
| Form 10-Q Edwards Lifesciences For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | -0.13% | -0.54% | |
| Edwards Lifesciences Announces CFO Transition Plan | Press release | Business Wire | +3.65% | -1.21% | |
| Edwards Lifesciences Reports Third Quarter Results | Press release | Business Wire | +3.65% | -1.21% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the EW section they belong to.
Where else EW is measured.
EW earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| PerkinElmer, Inc. (PKI) | 1,409 | +0.11% | 56% |
| Zoetis Inc. Class A (ZTS) | 1,401 | +0.02% | 51% |
| Lantheus Holdings, Inc. (LNTH) | 1,384 | -0.04% | 47% |
| Cardiovascular Systems, Inc. (CSII) | 1,376 | +0.05% | 53% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Edwards Lifesciences Corporation's median reaction calculated?
Every labeled EW news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 1,398 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 49% of EW's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does EW's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.